$WORX

SCWorx Corp. (WORX): Submission of Matters to a Vote of Security Holders

SCWorx Corp. (WORX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001674227 0001674227 2026-07-22 2026-07-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

Original reporting
Published Jul 23, 2026, 2:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 23, 2026, 2:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$WORX
Neutral
medium confidence
Mentioned
$WORX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WORXNeutralLow
01

Why it matters

The key actionable corporate event is shareholder approval of a certificate amendment authorizing a reverse stock split within a board-determined range (1/1.5 to 1/20) to regain Nasdaq Rule 5550(a)(2) compliance (minimum $1.00 bid).

02

Market read

Final vote confirmation reduces uncertainty about whether the reverse-split amendment can proceed, but the board still determines the exact ratio and timing.

03

What to watch

The filing also includes director elections and non-binding executive compensation voting, but those items are routine and likely less tradable than the reverse-split authorization itself.

Relevance 6/10Novelty 4/10Timing: post-annual-meeting, same-day SEC 8-K disclosure of final vote results

Background

SCWorx filed an 8-K (Item 5.07) reporting final results from its July 22, 2026 annual meeting of stockholders.

Company-level read

Ticker impact

$WORXNeutralMedium confidence
Context

SCWorx reported final 8-K voting results, including a proposal to authorize a reverse stock split to regain Nasdaq $1.00 bid compliance.

Expected impact

Near-term volatility possible around reverse-split implementation details, but direction is uncertain because the ratio is still board-determined within the stated range.

Evidence & confidence

The 8-K provides final vote counts for the reverse-split amendment, but does not disclose the final split ratio or immediate execution timing, limiting precision on price impact.

Market effects

Limited sector read-across; reverse-split mechanics are company-specific and typically do not change industry fundamentals.

Minimal, as the event is tied to Nasdaq listing compliance for a single microcap.

Low, no cross-border deal, regulation, or macro linkage described.

Counterpoint

Because the reverse-split ratio is not yet fixed, traders may overreact to the authorization; actual implementation could be delayed or structured to minimize disruption.

Key entities

  • SCWorx Corp.

    Company filing the 8-K and subject of the shareholder vote results.

  • Nasdaq Rule 5550(a)(2)

    Minimum $1.00 bid price requirement referenced as the compliance driver for the reverse split.

  • Astra Audit & Advisory, LLC

    Independent auditor ratified for the year ended December 31, 2026.

Related articles

$WORXHigh

SCWorx Announces Resumption of Nasdaq Trading and Highlights Improved Operating Performance and Growth Strategy

SCWorx Corp. (Nasdaq: WORX) resumed trading on Nasdaq after regaining compliance with listing requirements. The company reported improved operating performance, with Q2 2026 revenue of $706,000 and gross profit up 83% YoY. Net loss declined significantly, and cash usage decreased. SCWorx aims to grow its healthcare customer base and leverage AI for data management.

$WORXMed

SCWorx Corp. (WORX): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

SCWorx Corp. (WORX) filed an SEC Form 8-K — Other Events. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Summary Company Completed Offering to Cure Nasdaq Publicly Held Shares Deficiency and Submitted Request for Reconsideration; Common Stock Continues to Be Quoted on OTCQB

Med

SCWorx Corp.: SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company's Continued Listing on the Nasdaq Capital Market

SCWorx Corp. said Nasdaq’s Hearings Panel issued a partial compliance letter confirming completion of the first benchmark in its approved plan to regain compliance for continued listing. The remaining requirement is to meet the Nasdaq minimum bid price of at least $1.00 for 20 consecutive trading days, under Listing Rule 5815(c)(4).